<bill session="115" type="h" number="4275" updated="2019-04-18T16:17:35Z">
  <state datetime="2018-06-12T17:40:48-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2018-06-12T17:40:48-04:00"/>
  </status>
  <introduced datetime="2017-11-07"/>
  <titles>
    <title type="official" as="introduced">To provide for the development and dissemination of programs and materials for training pharmacists, health care providers, and patients on indicators that a prescription is fraudulent, forged, or otherwise indicative of abuse or diversion, and for other purposes.</title>
    <title type="short" as="passed house">Empowering Pharmacists in the Fight Against Opioid Abuse Act</title>
    <title type="short" as="passed house">Empowering Pharmacists in the Fight Against Opioid Abuse Act</title>
    <title type="short" as="introduced">Empowering Pharmacists in the Fight Against Opioid Abuse Act</title>
    <title type="short" as="introduced">Empowering Pharmacists in the Fight Against Opioid Abuse Act</title>
    <title type="display">Empowering Pharmacists in the Fight Against Opioid Abuse Act</title>
  </titles>
  <sponsor bioguide_id="D000623"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2018-05-09"/>
    <cosponsor bioguide_id="B001295" joined="2018-06-12"/>
    <cosponsor bioguide_id="C001103" joined="2017-11-07"/>
    <cosponsor bioguide_id="G000584" joined="2018-04-18"/>
    <cosponsor bioguide_id="H001078" joined="2018-03-13"/>
    <cosponsor bioguide_id="H001056" joined="2018-05-24"/>
    <cosponsor bioguide_id="J000297" joined="2018-03-05"/>
    <cosponsor bioguide_id="K000382" joined="2018-03-20"/>
    <cosponsor bioguide_id="P000611" joined="2018-05-09"/>
    <cosponsor bioguide_id="R000603" joined="2018-03-13"/>
    <cosponsor bioguide_id="S001196" joined="2018-02-27"/>
    <cosponsor bioguide_id="W000791" joined="2018-05-10"/>
  </cosponsors>
  <actions>
    <action datetime="2017-11-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-11-07" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-11-10">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-04-25">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2018-04-25">
      <text>Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .</text>
    </action>
    <action datetime="2018-05-09">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2018-05-09" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </calendar>
    <action datetime="2018-06-12T17:31:58-04:00">
      <text>Mr. Walden moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2018-06-12T17:32:17-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H5066-5067" label="consideration"/>
    </action>
    <action datetime="2018-06-12T17:32:19-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4275.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2018-06-12T17:40:48-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H5066" label="text"/>
    </vote>
    <action datetime="2018-06-12T17:40:50-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2018-06-13">
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Markup, Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="6"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Government information and archives"/>
    <term name="Health personnel"/>
    <term name="Health promotion and preventive care"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-12T13:55:19Z" status="Passed House amended">Empowering Pharmacists in the Fight Against Opioid Abuse Act

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.

HHS must seek input from relevant stakeholders.</summary>
  <committee-reports/>
</bill>
